Brock E. Schroeder
0000-0002-0803-7209
Publication & Citation Trends
Publications
0 total
Advancing access to genome sequencing for rare genetic disorders: recent progress and call to action OA
Cited by 9
Semantic Scholar
Real-World Impact of Comprehensive Genomic Profiling on Biomarker Detection, Receipt of Therapy, and Clinical Outcomes in Advanced Non–Small Cell Lung Cancer OA
Cited by 10
Semantic Scholar
Differences in baseline characteristics and healthcare costs among insured patients with advanced cancer with vs without clinical trial participation.
Cited by 0
Semantic Scholar
Real-world analysis of commercially insured and Medicare Advantage patients with advanced cancer and rates of molecular testing.
Cited by 3
Semantic Scholar
Improved outcomes from reflex comprehensive genomic profiling-guided precision therapeutic selection across a major US healthcare system.
Cited by 2
Semantic Scholar
Abstract 14482: Low Utilization of Guideline-Recommended Genetic and Pharmacogenetic Testing Among Patients With Cardiovascular Conditions in the United States (US)
Cited by 1
Semantic Scholar
Biomarker testing rates among metastatic cancer patients with receipt of anti-cancer systemic therapy: A real-world data analysis.
Cited by 0
Semantic Scholar
System dynamics simulation for evaluating implementation strategies of genomic sequencing: tutorial and conceptual model OA
Cited by 7
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(39)
Cancer Genomics and Diagnostics
(27)
Advanced Breast Cancer Therapies
(16)
BRCA gene mutations in cancer
(14)
Cancer Risks and Factors
(14)
Affiliations
Linköping University
University of Wisconsin System
Karolinska University Hospital
University of Wisconsin–Madison
Illumina (United States)